Innovation Pharmaceuticals Stock Today
| IPIX Stock | USD 0.0003 0.0002 200.00% |
Performance19 of 100
| Odds Of DistressOver 60
|
Innovation Pharmaceuticals is trading at 3.0E-4 as of the 3rd of December 2024; that is 200.00 percent increase since the beginning of the trading day. The stock's open price was 1.0E-4. Innovation Pharmaceuticals has more than 60 % chance of experiencing financial distress in the next few years of operation. However, it had a very solid returns during the last 90 days. Equity ratings for Innovation Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 14th of December 2022 and ending today, the 3rd of December 2024. Click here to learn more.
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts. The company has 488.32 M outstanding shares. More on Innovation Pharmaceuticals
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Innovation Pink Sheet Highlights
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Innovation Pharmaceuticals [IPIX] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.52 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Innovation Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Innovation Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Innovation Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 488.32 M outstanding shares.
Innovation Pharmaceuticals currently holds about 2.97 M in cash with (6.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Innovation Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationInnovation Pharmaceuticals has a total of 488.32 Million outstanding shares. Innovation Pharmaceuticals retains 10.1 (percent) of its outstanding shares held by insiders and 0.0 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Innovation Ownership Details
Innovation Pharmaceuticals Risk Profiles
| Mean Deviation | 38.63 | |||
| Semi Deviation | 28.91 | |||
| Standard Deviation | 55.6 | |||
| Variance | 3091.46 |
Innovation Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Innovation Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Innovation Pharmaceuticals Corporate Management
| Leo CPA | CEO, Chairman | Profile | |
| MS MP | VP Management | Profile | |
| Jim Boeheim | B Advisor | Profile | |
| James Alexander | Consultant | Profile |
Additional Tools for Innovation Pink Sheet Analysis
When running Innovation Pharmaceuticals' price analysis, check to measure Innovation Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation Pharmaceuticals is operating at the current time. Most of Innovation Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Innovation Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation Pharmaceuticals' price. Additionally, you may evaluate how the addition of Innovation Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.